Life science is our single focus and always has been. At CanaleComm, we intimately understand the industry landscape and are uniquely equipped to translate your business objectives into a communications strategy that works.
The CanaleComm team did so much to develop the profile of Lumena, helping us go very far in a short amount of time. I’ve always appreciated the support they’ve provided to the company and to me, personally. Now that Lumena has sold, we’ve enlisted the CanaleComm team to build a reputation for our newest endeavor.
Mike GreyPappas Ventures and Former CEO and Co-founder, Lumena Pharmaceuticals Inc.
Selecting CanaleComm as our communication agency has been one of the best business decisions we’ve made. Their amazing efforts have led to a massive influx of customer and partner requests, some of which have come from the largest companies in the world. The team is highly motivated, very polished, extremely well connected and incredibly focused.
Gavin StoneSenior Director of Marketing, Edico Genome Inc.
Canale Communications effectively helped us hone our messaging to meet these potentially disparate goals and further understand our market position. The website that was ultimately launched not only translated our core values, corporate culture and service offerings, it’s design served as a platform for our print, electronic and trade-show marketing.
Erica SmithSenior Director, Commercial Sales and Marketing, Lovelace Biomedical
I’ve worked with many agency partners but CanaleComm really stands out; I call them my secret weapon. They are a true extension of our in-house team. When I joined Prothena in 2015 it was an easy decision for me to bring CanaleComm in to assist us with our messaging and a variety of other communication needs.
Ellen RoseHead of Communications, Prothena Corporation plc (NASDAQ: PRTA)
CanaleComm has provided critical support to our business development and partnering activities, helping to move the perception of Second Genome from ‘very early stage’ to ‘clinical stage with incredible momentum.’ This public relations strategy has supported our efforts to secure meetings and advance dialogues with pharmaceutical companies.
Mohan IyerChief Business Officer, Second Genome Inc.
Across multiple major data and financing announcements and the ultimate acquisition of Naurex, CanaleComm was able to effectively manage all of our PR needs, resulting in broad and impactful coverage through an array of media channels. We are pleased to continue our relationship and work with CanaleComm to ensure successful communication initiatives at our new spin-out company, Aptinyx.
Ashish KhannaChief Business Officer, Aptinyx Inc.
Truly amazing! In all my years of working with PR and Media firms, this experience was by far the best. In addition to setting a record on turnaround time, the results were just remarkable.
We translate even the most complicated science into powerful narratives that capture the attention of your target audience. We know what makes a great story—and reporters respect that.
From prepping for the road show to developing engaging conference call scripts, we help you demonstrate value in a way that resonates with investors. It requires creativity and good storytelling, not just facts and figures.
You’ll never get the template approach from us. We develop a custom look for every client, with the goal of moving from the one “big project” to becoming your ongoing creative partner.